House Bill 1418 would create the Mississippi “Right to Contraception Act” and declare the right to obtain and use contraception a statutory fundamental right tied to privacy, health, dignity, liberty, equality, and participation in social and economic life. The bill defines contraception broadly to include contraceptive drugs, devices, fertility-awareness methods, and sterilization procedures, and it defines contraceptives to include a wide range of FDA-marketed products such as oral contraceptives, emergency contraception, condoms, patches, rings, injectables, and long-acting reversible contraceptives.
The bill would prohibit the state and its political subdivisions from enforcing laws or rules in a way that restricts FDA-approved contraceptives, prevents people from helping others obtain them, or makes their sale, provision, or use more difficult. It also creates a private right of action and authorizes the Attorney General to sue for violations, with courts able to grant injunctive relief and award costs and attorney’s fees to prevailing plaintiffs. The bill expressly says it does not require insurance plans to cover specific benefits and does not authorize sterilization without voluntary and informed consent.
In addition to the general right-to-contraception provisions, HB1418 would expand pharmacy access by creating a new code section authorizing pharmacists to provide hormonal contraceptives under collaborative practice agreements and standardized procedures. The bill requires pharmacist training, patient screening and counseling materials, referral information for follow-up care, and rules from the State Board of Pharmacy and State Board of Medical Licensure. It also allows pharmacists to charge an administrative fee in some cases, preserves existing insurance coverage rules, provides immunity from certain disciplinary and civil liability claims when acting in good faith, and allows conscientious refusal only if the pharmacist refers the patient elsewhere.
The bill’s impact on state law would be significant because it would add an explicit statutory protection for contraception access and constrain state and local restrictions that single out contraceptives or contraceptive information. It would also amend Mississippi pharmacy law to treat pharmacist-provided hormonal contraception as part of the practice of pharmacy and to set statewide procedures for dispensing. The bill would leave existing health insurance coverage provisions in place, but it would strengthen legal remedies for patients, providers, and others affected by restrictions.
No committee transcript or vote history was provided, so there is no recorded discussion or roll-call evidence of support or opposition in the materials supplied. Based on the bill text alone, the measure appears designed to affirm and expand access to contraception, while preserving conscience protections and some existing insurance and consent rules. The main likely points of contention are the declaration of contraception as a fundamental right, the broad limits on government regulation, the private enforcement mechanism, and the pharmacist-dispensing provisions, especially as they relate to minors, administrative fees, and conscience-based refusals.
HB1418 would create new statutory protections for contraception access in Mississippi, limit state and local restrictions on FDA-approved contraceptives, and authorize civil enforcement by the Attorney General and private parties. It would also amend pharmacy law to allow pharmacists to furnish hormonal contraceptives under collaborative practice agreements and standardized protocols, while preserving existing insurance coverage rules and conscience protections.
No committee discussion or vote record was provided, so there is no documented legislative sentiment in the supplied materials. From the bill text, the measure is clearly framed in supportive terms as an access-and-rights bill, but it also anticipates opposition by including conscience protections, consent requirements, and a narrow statement that it does not mandate insurance benefits.
The most notable points of contention are likely to be the bill’s declaration that contraception is a fundamental right, its restriction on state and local regulation that could impede access, and its private right of action allowing affected individuals and entities to sue. Additional likely disputes involve pharmacist authority to dispense hormonal contraceptives, the age limits for pharmacist-provided contraception, the administrative fee provision, and the balance between access and conscience objections for pharmacists who decline to provide contraception.